By putting its name on allegedly defective vaginal mesh implants, American Medical Systems held itself out as the manufacture of those devices, according to an amended class action pleading that addresses the medical device maker’s assertion that a subsidiary made the devices after May 2012.
Funding for a shareholder class action against mineral sands company Iluka Resources is in doubt after Harbour Litigation Funding unilaterally backed out of an agreement to finance the litigation.
A judge has rejected a bid by former directors of Slater & Gordon to throw out cross claims brought by Pitcher Partners in two shareholder class actions alleging the accounting firm wrongly signed off on the law firm’s financial reports ahead of a share price nosedive, saying it was possible Pitcher Partners’ claimed reliance on representations by the directors was reasonable.
Charges in the criminal cartel case against ANZ, Citigroup and Deutsche Bank over a $2.5 billion ANZ institutional share placement have yet to be finalised, almost a year after the proceeding was filed.
Liquidators of failed Centaur Litigation have reached a settlement in their lawsuit against the accountant of fraudster Scott Williams, who was accused of lying to hide his knowledge of a Ponzi scheme that misappropriated $32 million and led to the collapse of the funder.
ANZ Bank executives briefly considered relaunching and repricing a botched $2.5 billion equity capital raising at the heart of two groundbreaking enforcement actions, and the decision by the share placement’s underwriters to instead pick up a $790 million shortfall deprived investors of lower priced shares, a court has been told.
The Commonwealth Bank has been hit with a lawsuit by a former general manager who claims his retrenchment in 2013 violated the whistleblower protections under the Corporations Act.
An appeals court has reimposed penalties against the Construction, Forestry, Maritime, Mining and Energy Union, its NSW branch and nine officials for unlawful industrial action at Barangaroo, but dropped the total fine from $2.5 million to $1.7 million.
A judge has scheduled a two-day hearing to hear a dispute between investment group Caason Investments, a lead applicant in a shareholder class action against defunct laser technology company Arasor that settled last year for $19.25 million, and Singapore-based litigation funder International Litigation Partners over personal costs allegedly owed to the investment group under a “secret” side agreement.
Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should be revoked.